Neurizon inks $1.5M loan against R&D Tax Rebate
Neurizon Therapeutics (ASX:NUZ) retreated in intra-day trade on Wednesday after inking a non-dilutive loan agreement for $1.5 million to fund its current and future operations seeking to treat Huntington’s with its flagship drug NUZ-001.The funds in question are secured against it...
Currently unlisted.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
CTL | CTL Administration | 18/05/21 | 23 | 14K | |||
|
|||||||
CTL | Ann: Update on the DOCA and Meeting of Creditors | 29/03/20 | 11 | 11K | |||
|
|||||||
CTL | Ann: Removal from Official List - Annual Listing Fees | 23/02/20 | 56 | 34K | |||
|
|||||||
CTL | Ann: DOCA Update | 27/08/19 | 5 | 4.8K | |||
|
|||||||
CTL | DOCA Update - CTL Potentially Merging with AUL | 23/08/19 | 2 | 2.0K | |||
|
|||||||
CTL | Ann: DOCA Update | 20/08/19 | 29 | 21K | |||
|
|||||||
CTL | Ann: AUL:AuStar enters discussions with Centennial Administrators | 08/08/19 | 18 | 8.5K | |||
|
|||||||
CTL | Audit inquiry | 02/08/19 | 0 | 747 | |||
|
See All Discussions